Ozempic works by mimicking a natural gut hormone called GLP-1, which your small intestine produces after you eat. This hormone normally helps regulate blood sugar and appetite, but it breaks down in minutes. Semaglutide, the active ingredient in Ozempic, is engineered to last much longer, staying active in your body for about a week. That sustained activity lets it reduce appetite, slow digestion, and change how your brain processes hunger signals, all of which contribute to significant weight loss.
How GLP-1 Works in Your Body
Every time you eat, your small intestine releases GLP-1 into your bloodstream. This hormone does several things at once: it tells your pancreas to release insulin so your cells can use the sugar from your meal, it slows down how quickly food leaves your stomach, and it signals your brain that you’re full. It also blocks the release of glucagon, a hormone that raises blood sugar. Together, these effects keep your blood sugar stable and help regulate how much you eat.
The problem is that natural GLP-1 disappears from your bloodstream within minutes. Semaglutide is a synthetic version designed to bind to the same receptors and trigger the same responses, but with a structure that resists breakdown. One weekly injection keeps GLP-1 receptors activated continuously, amplifying effects that your body normally experiences only briefly after meals.
Three Ways It Drives Weight Loss
Reduced Appetite
The most powerful weight loss effect comes from the brain. Semaglutide activates GLP-1 receptors in areas of the brain that process hunger and fullness. People on the medication consistently report feeling satisfied with smaller portions and experiencing fewer cravings between meals. This isn’t about willpower. The drug changes the neurological signals that drive you to eat, making it genuinely easier to consume less food without feeling deprived.
Slower Digestion
Semaglutide significantly slows gastric emptying, meaning food stays in your stomach longer. This creates a prolonged feeling of fullness after eating. In studies using endoscopy, 24% of patients on semaglutide had residual food in their stomachs compared to just 5% of people not taking the drug. This slower digestion also means sugar from your meals enters your bloodstream more gradually, reducing the blood sugar spikes that can trigger hunger.
Lower Blood Sugar Fluctuations
By boosting insulin release and blocking glucagon at the same time, semaglutide keeps blood sugar levels steadier throughout the day. Stable blood sugar reduces the crashes that often lead to snacking and overeating. This is also why Ozempic was originally developed for type 2 diabetes: blood sugar regulation is its primary approved use.
How Much Weight People Actually Lose
Clinical trial results give a clear picture. In the STEP UP trial, participants taking the higher 2.4 mg dose of semaglutide lost an average of 15.6% of their body weight. A newer 7.2 mg dose (not yet widely available) pushed that figure to 18.7%. For comparison, participants on a placebo lost only 3.9%. For someone weighing 220 pounds, a 15.6% reduction translates to roughly 34 pounds.
Weight loss is gradual. The medication starts at a low dose of 0.25 mg per week, which is intentionally below the therapeutic level. Over several weeks, the dose increases to allow your body to adjust. The maximum recommended Ozempic dose is 2 mg once weekly. Most people begin noticing meaningful weight changes after the first month or two of dose increases.
Ozempic Versus Wegovy
This is a common point of confusion. Ozempic and Wegovy contain the exact same active ingredient: semaglutide. The difference is their approved uses. Ozempic is FDA-approved for managing type 2 diabetes and reducing cardiovascular risk in people with diabetes. Wegovy is approved specifically for weight management in adults and children 12 and older, and its maximum dose is slightly higher at 2.4 mg versus Ozempic’s 2 mg.
When doctors prescribe Ozempic for weight loss, they’re using it “off-label,” meaning for a purpose beyond its official approval. The drug works the same way regardless of the label on the pen. But the distinction matters for insurance coverage, and Wegovy’s higher maximum dose may produce slightly more weight loss.
Common Side Effects
The most frequent side effects are gastrointestinal: nausea, vomiting, diarrhea, abdominal pain, and constipation. These affect more than 5% of users and tend to be worst during dose increases. Most people find that nausea improves after the first few weeks at each new dose level, which is why the gradual titration schedule exists.
The slowed gastric emptying that helps with appetite can sometimes go too far. There have been reports of severe gastroparesis, where the stomach empties extremely slowly, causing persistent nausea and discomfort. This effect on digestion can last up to 8 weeks even after stopping the medication. If you experience severe or persistent stomach symptoms, that’s worth discussing with your prescriber rather than pushing through.
What Happens When You Stop
Semaglutide does not permanently change your metabolism. It works by keeping GLP-1 receptors activated, and when the drug leaves your system, those receptors return to normal activity. Appetite typically increases back to baseline, digestion speeds up, and weight regain is common. This is why the World Health Organization’s 2025 guideline on GLP-1 medications describes them as a “long-term treatment” for obesity, paired with structured diet and physical activity changes that can help sustain results.
Building sustainable eating habits while on the medication gives you the best chance of maintaining weight loss if you eventually stop. The reduced appetite semaglutide provides can serve as a window to establish new portion sizes, food choices, and activity patterns that are harder to adopt when hunger signals are working against you.